CURATIVE BIOTECHNOLOGY, INC.Restricted Stock Award Agreement • November 24th, 2021 • Curative Biotechnology Inc • Biological products, (no disgnostic substances) • Florida
Contract Type FiledNovember 24th, 2021 Company Industry JurisdictionUnless otherwise defined herein, the terms defined in the Curative Biotechnology, Inc. 2021 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Award Agreement (the “Award Agreement”).
COMMON STOCK PURCHASE WARRANT CURATIVE BIOTECHNOLOGY, Inc.Security Agreement • November 24th, 2021 • Curative Biotechnology Inc • Biological products, (no disgnostic substances) • Florida
Contract Type FiledNovember 24th, 2021 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [*] (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Curative Biotechnology, Inc., a Florida corporation (the “Company”), up to 3,500,000 shares (the “Warrant Shares”) of common stock of the Company (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT CURATIVE BIOTECHNOLOGY, Inc.Security Agreement • November 24th, 2021 • Curative Biotechnology Inc • Biological products, (no disgnostic substances) • Florida
Contract Type FiledNovember 24th, 2021 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Paul Michaels (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Curative Biotechnology, Inc., a Florida corporation (the “Company”), up to 5,000,000 shares (the “Warrant Shares”) of common stock of the Company (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).